Effects of prepubertal indole-3-carbinol treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Sprague-Dawley rats

In Vivo

Volumn 21, Issue 6, 2007, Pages 983-988

  Shimano, Naoto ^a   Uehara, Norihisa ^a   Kiyozuka, Yasuhiko ^a   Shikata, Nobuaki ^a   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Indole 3 carbinol; Mammary cancer; Mammary tumor; N methyl N nitrosourea; Prepuberty; Sprague Dawley rat

Indexed keywords

3 INDOLEMETHANOL; METHYLNITROSOUREA;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG RESPONSE; ESTRUS CYCLE; FEMALE; NONHUMAN; ORGAN WEIGHT; OVARY WEIGHT; PREPUBERTY; RAT; SHORT COURSE THERAPY; SPRAGUE DAWLEY RAT; TREATMENT DURATION; UTERUS WEIGHT; VAGINA; WEIGHT GAIN;

EID: 37349014596     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Malin AS, Qi D, Shu XO, Gao YT, Friedmann JM, Jin F and Zheng W: Intake of fruits, vegetables and selected micronutrients in relation to the risk of breast cancer. Int J Cancer 105: 413-418, 2003.
2. Tsubura A, Uehara N, Kiyozuka Y and Shikata N: Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia 10: 87-100, 2005.
3. Rogan EG: The natural chemopreventive compound indole-3-carbinol: state of the science. In Vivo 20: 221-228, 2006.
4. Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF and Firestone GL: Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 273: 3838-3847, 1998.
5. Rahman KM, Li Y and Sarkar FH: Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 48: 84-94, 2004.
6. Telang NT, Katdare M, Bradlow HL, Osborne MP and Fishman J: Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol. Proc Soc Exp Biol Med 216: 246-252, 1997.
7. Rabman KM, Aranha O and Sarkar FH: Indole-3-carbinol (13C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells. Nutr Cancer 45: 101-112, 2003.
8. Stoewsand GS, Anderson JL and Munson L: Protective effect of dietary brussels sprouts against mammary carcinogenesis in Sprague-Dawley rats. Cancer Lett 39: 199-207, 1988.
9. Wattenberg LW and Loub WD: Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 38: 1410-1413, 1978.
10. Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kelloff GJ and Lubet RL: Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15: 709-716, 1995.
11. Bradlow HL, Michnovicz J, Telang NT and Osborne MP: Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12: 1571-1574, 1991.
12. Adami HO, Persson I, Ekbom A, Wolk A, Ponten J and Trichopoulos D: The actiology and pathogenesis of human breast cancer. Mutat Res 333: 29-35, 1995.
13. Ariazi JL, Haag J-D, Lindstrom MJ and Gould MN: Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N-nitroso-N-methylurea. Mol Carcinog 43: 155-164, 2005.
14. Gao X, Petroff BK, Oluola O, Georg G, Terranova PF and Rozman KK: Endocrine disruption by indole-3-carbinol and tamoxifen: blockage of ovulation. Toxicol Appl Pharmacol 183: 179-188, 2002.
15. Karim BO, Landolfi JA, Christian A, Ricart-Arbona R, Qiu W, McAlonis M, Eyabi PO, Khan KA, Dicello JF, Mann JF and Huso DL: Estrous cycle and ovarian changes in a rat mammary carcinogenesis model after irradiation, tamoxifen chemoprevention, and aging. Comp Med 53: 532-538, 2003.
16. Russo J, Russo IH, Rogers AE, van Zwieten MJ and Gusterson B: Tumours of the mammary gland. In: Pathology of Tumours in Laboratory Animals. Tumours of the Rat. Turusov V and Mohr U (eds.). Lyon, IARC Sci Publ, pp. 47-78, 1990.
17. Shertzer HG and Sainsbury M: Intrinsic acute toxicity and hepatic enzyme inducing properties of the chemoprotectants indole-3-carbinol and 5,10-dihydroindeno[1,2-b]indole in mice. Food Chem Toxicol 29: 237-242, 1991.
18. Malejka-Giganti D, Niehans GA, Reichert MA and Bliss RL: Post-initiation treatment of rats with indole-3-carbinol or beta-naphthoflavone does not suppress 7, 12-dimethylbenz[a] anthracene-induced mammary gland carcinogenesis. Cancer Lett 160: 209-218, 2000.
19. Stoner G, Casto B, Ralston S, Roebuck B, Pereira C and Bailey G: Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol. Carcinogenesis 23: 265-272, 2002.
20. Kang IS, Kim DJ, Ahn B, Nam KT, Kim KS, Choi M and Jang DD: Post-initiation treatment of indole-3-carbinol did not suppress N-methyl-N-nitrosourea induced mammary carcino-genesis in rats. Cancer Lett 169: 147-154, 2001.
21. Chen I, McDougal A, Wang F and Safe S: Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19: 1631-1639, 1998.
22. Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL and Bjeldanes LF: 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26: 771-778, 2005.
23. Kim DJ, Han BS, Ahn B, Hasegawa R, Shirai T, Ito N and Tsuda H: Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in a rat medium-term multiorgan carcinogenesis model. Carcinogenesis 18: 377-381, 1997.